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PPRE-CLINICAL RESEARCH
Impaired Infarct Healing in
Atherosclerotic Mice With Ly-6Chi Monocytosis
Peter Panizzi, PHD,*‡ Filip K. Swirski, PHD,*‡ Jose-Luiz Figueiredo, MD,*‡ Peter Waterman, BS,*‡
David E. Sosnovik, MD,†‡ Elena Aikawa, MD, PHD,‡ Peter Libby, MD,§ Mikael Pittet, PHD,*
Ralph Weissleder, MD, PHD,*‡ Matthias Nahrendorf, MD, PHD*‡
Boston and Charlestown, Massachusetts
Objectives The aim of this study was to test whether blood monocytosis in mice with atherosclerosis affects infarct healing.
Background Monocytes are cellular protagonists of tissue repair, and their specific subtypes regulate the healing program
after myocardial infarction (MI). Inflammatory Ly-6Chi monocytes dominate on Day 1 to Day 4 and digest
damaged tissue; reparative Ly-6Clo monocytes dominate on Day 5 to Day 10 and promote angiogenesis and
scar formation. However, the monocyte repertoire is disturbed in atherosclerotic mice: Ly-6Chi monocytes expand
selectively, which might disrupt the resolution of inflammation.
Methods Ex vivo analysis of infarcts included flow cytometric monocyte enumeration, immunoactive staining, and quanti-
tative polymerase chain reaction. To relate inflammatory activity to left ventricular remodeling, we used a combi-
nation of noninvasive fluorescence molecular tomography (FMT-CT) and physiologic imaging (magnetic reso-
nance imaging).
Results Five-day-old infarcts showed 10 more Ly-6Chi monocytes in atherosclerotic (apoE/) mice compared with
wild-type mice. The injured tissue in apoE/ mice also showed a more pronounced inflammatory gene expres-
sion profile (e.g., increased tumor necrosis factor-alpha and myeloperoxidase and decreased transforming
growth factor-beta) and a higher abundance of proteases, which are associated with the activity of Ly-6Chi mono-
cytes. The FMT-CT on Day 5 after MI showed higher proteolysis and phagocytosis in infarcts of atherosclerotic
mice. Serial magnetic resonance imaging showed accelerated deterioration of ejection fraction between Day 1
and Day 21 after MI in apoE/. Finally, we could recapitulate these features in wild-type mice with artificially
induced Ly-6Chi monocytosis.
Conclusions Ly-6Chi monocytosis disturbs resolution of inflammation in murine infarcts and consequently enhances left ven-
tricular remodeling. These findings position monocyte subsets as potential therapeutic targets to augment tissue
repair after infarction and to prevent post-MI heart failure. (J Am Coll Cardiol 2010;55:1629–38) © 2010 by
the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.08.089v
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sn the first week after coronary occlusion, the myocardium
xperiences high cell and extracellular matrix turnover (1–4)
nd is exposed to the constant stress of cycling intracardiac
ressures. The quality of infarct healing determines the
echanical properties of the injured tissue and therefore
rognosis: poor healing might lead to infarct rupture or left
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Manuscript received July 2, 2009, accepted August 16, 2009.entricular dilation due to infarct expansion (5). Timely
eperfusion therapy reduces acute infarct mortality (6), and
urrent standard of care attenuates post-myocardial infarc-
ion remodeling (7,8). However, present therapies typically
ave modest long-term effects: for example, the SAVE trial
See page 1639
ndicated that angiotensin-converting enzyme inhibitors can
nly reduce infarct mortality from 25% to 20% (9); and
ortality remains even higher in patients with end-stage
eart failure (10). Thus, there is a need to better understand
he complex cellular and molecular constituents that regu-
ate myocardial healing and remodeling, because they might
erve as biomarkers and therapeutic targets for the predic-
ion and prevention of heart failure.
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Fluorescence Molecular Tomography-CT in Infarcted ApoE/ Mice April 13, 2010:1629–38Recruitment of monocytes
from the bloodstream into the
vessel wall drives atherosclerotic
plaque growth and vulnerability
(11). Blood levels of inflamma-
tory Ly-6Chi monocytes increase
profoundly in atherosclerotic
mice (12,13), and peripheral
monocytosis occurs in patients
with coronary artery disease
(14,15). At the same time, Ly-
6Chi monocytes dominate in the
myocardial wound on Day 1 to
Day 4 after coronary ligation and
digest necrotic tissue (monocytic
Phase 1) (16). During a second
monocytic phase that ensues di-
rectly (Phase 2), the number of
Ly-6Chi monocytes declines rap-
idly while reparative Ly-6Clo
monocytes accumulate and prop-
agate healing and the resolution
of inflammation. Abrogation of
either monocytic phase results in
poor healing, indicating that suc-
cessful cardiac wound repair de-
pends on a well-coordinated bi-
hasic monocyte response (16). The present study tested the
ypothesis that atherosclerosis-associated Ly-6Chi blood
onocytosis interferes with resolution of inflammation during
he monocytic Phase 2 of infarct healing. We hypothesized
hat, on the basis of clinical data showing that blood monocy-
osis independently associates with heart failure after MI
17,18), pre-existing blood monocytosis in atherosclerotic mice
ncreases and prolongs the presence of Ly-6Chi monocytes in
he infarct, interferes with resolution of inflammation after
schemic injury, enhances LV remodeling, and thus ultimately
avors heart failure. This hypothesis has considerable clinical
elevance, because inflammation predisposes to complications
f atherosclerosis such as acute MI (11).
Although inflammation is typically assessed with ex vivo
echniques, noninvasive tools that gauge inflammation can
e used to relate innate immune cell function in the infarct
ith ventricular dilation and subsequent development of
eart failure. Here we used fluorescence molecular tomog-
aphy in conjunction with anatomical computed tomogra-
hy (FMT-CT) and magnetic resonance imaging for in vivo
ssessment of cellular responses and physiological conse-
uences otherwise hard to measure longitudinally.
ethods
ouse model. C57B/6 and apolipoprotein E knockout
apoE/) mice were purchased from Jackson Laboratories
Bar Harbor, Maine). ApoE/ mice had an average age of
Abbreviations
and Acronyms
apoE/  apolipoprotein
E knockout
CT  computed
tomography
EDV  end-diastolic volume
FMT-CT  fluorescence
molecular tomography X-ray
computed tomography
Gd-DTPA  gadolinium-
diethylenetriaminepentaacetic
acid
LPS  lipopolysaccaride
LV  left
ventricle/ventricular
MI  myocardial infarction
MMP  matrix
metalloproteinase
MPO  myeloperoxidase
MRI  magnetic resonance
imaging
VEGF  vascular
endothelial growth factor
3D  3-dimensional5 weeks and were on a high-cholesterol diet (0.2% total Sholesterol) (Harlan Teklad, Madison, Wisconsin). An MI
as induced by coronary ligation as described before (19).
e first conducted an invasive study that assessed monocyte
umbers and the quality of inflammation and healing by
ow cytometric and molecular profiling of infarcts harvested
n Day 5 after MI. We next investigated the interrelation of
nfarct healing and ventricular dilation in a longitudinal trial
ith serial MRI on Day 1 and Day 21 and FMT-CT
maging on Day 5 after MI. To study the impact of blood
onocytosis on infarct healing in a model independent of
ipid metabolism, we induced blood monocytosis in C57B/6
ice (50 g of lipopolysaccharide [Sigma, St. Louis, Mis-
ouri] IP injections [20] 24 h before and on Days 1, 2, 3,
nd 4 after MI). The contribution of neutrophils to healing
n apoE/ mice was assessed in a cohort in which we
epleted neutrophils (500 mg IP injections of anti Ly-6G
ntibody [BioXCell, West Lebanon, New Hampshire] 24 h
efore and on Day 1 and Day 3 after MI). The experimental
rotocol and animal numbers are outlined in Figure 1. The
ocal institutional animal welfare committee approved the
esearch reported.
low cytometry. On Day 5 after MI, peripheral blood and
nfarct tissue were prepared for flow cytometric quantitation
f leukocytes as described before (16). Cell suspensions were
ncubated with a cocktail of monoclonal antibodies against
cells (CD90-PE, 53-2.1), B cells (B220-PE, RA3-6B2),
K cells (CD49b-PE, DX5 and NK1.1-PE, PK136),
ranulocytes (Ly-6G-PE, 1A8), myeloid cells (CD11b-
PC, M1/70), antigen-presenting cells (I-Ab (AF6-120.1)-
iotin-Strep-PerCP), and monocyte subsets (Ly-6C-FITC,
L-21) (BD Biosciences, San Jose, California). Monocytes
ere identified as CD11bhi (CD90/B220/CD49b/NK1.1/
y-6G)lo (F4/80/I-Ab/CD11c)lo Ly-6Chi/lo. Macrophages/
endritic cells were identified as CD11bhi (CD90/B220/
D49b/NK1.1/Ly-6G)lo (I-Ab/CD11c)hi Ly-6Clo.
eutrophils were identified as CD11bhi (CD90/B220/
D49b/NK1.1/Ly-6G)hi (I-Ab/CD11c)lo Ly-6Cint.
onocyte and macrophage cell numbers were calculated as
otal cells multiplied by percent cells within the monocyte/
acrophage gate. Within this population, monocyte subsets
ere identified as (I-Ab/CD11c)lo and either Ly-6Chi or
y-6Clo. For assessment of proteolytic activity including
athepsins, 5 nmol Prosense-680 (VisEn Medical, Bedford,
assachusetts) was injected into the tail vein 24 h before
he animal was killed. For assessment of phagocytic activity,
LIO-VT750 (Center for Molecular Imaging Research
hemistry Core, Boston, Massachusetts), 15 mg of iron/kg
odyweight (21), was injected into the tail vein 24 h before
he animal was killed. Data were acquired on an LSRII (BD
iosciences).
athology. IMMUNOREACTIVE STAINING. Serial 6 m-
hick sections were stained for neovessels (CD31, BD
harmingen, San Diego, California), vascular endothelial
rowth factor (VEGF) (Abcam, Cambridge, United King-
om), proteases (cathepsin B [Santa Cruz Biotechnology,
anta Cruz, California] and matrix metalloproteinase
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April 13, 2010:1629–38 Fluorescence Molecular Tomography-CT in Infarcted ApoE/ MiceMMP]-2 and MMP-9 [Millipore, Billerica, Massachu-
etts]), and macrophages (F4/80, Abcam). We quantified
he percentage positive area within the field of view with 5
igh-power fields (magnification 200) per section and per
nimal.
LUORESCENCE REFLECTANCE IMAGING. On Day 5 after
I, short-axis rings were imaged at 4 magnification
OV-110, Olympus, Center Valley, Pennsylvania) in the
80 nm and 750 nm channels 24 h after injection of
rosense-680 and CLIO-750.
UANTITATIVE POLYMERASE CHAIN REACTION. Multiplex
uantitative polymerase chain reaction was performed on
riplicate samples with Applied Biosystems (Foster City,
alifornia) TaqMan assays. Infarct tissue was examined for
xpression of markers of inflammatory monocytes (Ly-6C,
m00841873_m1), differentiated macrophages (CD68,
m00839636_g1; Mac3, Mn00495267_m1), tumor necro-
is factor-alpha (Mm00443258-m1), myeloperoxidase
MPO) (Mm00447886_m1), transforming growth factor-
eta (Mm00436971_m1), and appropriate controls
glyceraldehyde-3-phosphate dehydrogenase, apoE).
maging. To evaluate the prognostic significance of ex vivo
ndings, we assessed monocyte-associated biomarkers in
he infarct and followed, in parallel, LV remodeling in the
ame cohort of mice. This approach used FMT-CT as a
olecular imaging tool and MRI to quantitate physiological
ariables, a powerful and effective combination to follow the
Figure 1 Experimental Protocol
Experimental protocol ex vivo (A, C) and in vivo (B, D) studies. DE MRI  delayed
rescence activated cell sorting; FMT-CT  fluorescence molecular tomography in c
ing; IHC  immunohistochemistry; MI  myocardial infarction induced by coronaryvents after MI longitudinally. cMT-CT. To validate the FMT-CT fusion algorithm, we
sed a tissue phantom filled with a solution of 30 l CT
ontrast (Isovue-370, Bracco, Princeton, New Jersey) and 1
mol of the fluorochrome VT-680 (VisEn Medical). With
n FMT 2500 system (VisEn Medical), we acquired 30
rontal slices of 0.5 mm thickness in the z-direction, with an
n-plane resolution of 1  1 mm. Data were post-processed
ith a normalized Born forward equation to calculate
-dimensional fluorochrome concentration maps. The
hantom was then imaged by CT while positioned in a
ultimodality cartridge.
On Day 5 after MI, 1 day after onset of the monocytic Phase
(16), we performed dual channel (680/700 nm and 750/800
m excitation/emission) FMT-CT imaging to interrogate the
agnitude and quality of inflammation 24 h after injection of
nmol of a pan-cathepsin protease sensor (Prosense-680) and
5 mg/kg body weight CLIO-750, nanoparticles prone to be
ngested by phagocytes (21). A 3D dataset was reconstructed in
hich fluorescence/voxel was expressed in nmol/l. To robustly
dentify the region of interest in the heart, anatomic imaging
ith CT immediately followed FMT. The imaging cartridge
ontaining the anesthetized mouse was placed into the custom-
achined Plexiglas holder that supplies isoflurane, warm air,
nd optimal positioning in the CT (Inveon PET-CT, Sie-
ens, Malvern, Pennsylvania). The CT X-ray source operated
t 80 kVp and 500A with an exposure time of 370 to 400 ms.
he effective 3D resolution was 80 m isotropic. Isovue-370
as infused intravenously at 55 l/min through a tail-vein
cement magnetic resonance imaging for infarct size measurement; FACS  fluo-
tion with anatomical computed tomography; FRI  fluorescence reflectance imag-
n; PCR  polymerase chain reaction-based gen expression profiling.enhan
onjunc
ligatioatheter. The CT reconstruction protocol performed bilinear
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Fluorescence Molecular Tomography-CT in Infarcted ApoE/ Mice April 13, 2010:1629–38nterpolation, used a Shepp-Logan filter, and scaled pixels to
ounsfield units.
MAGE FUSION. The fusion method realized 3D mapping of
uorescence within the anatomical reference CT. The
pproach was based on a multimodality-compatible animal-
olding device that provides fiducial landmarks on its frame.
he imaging cartridge lightly compressed the anesthetized
ouse between optically translucent windows and thereby
revented motion during transfer between modalities. The
D distribution of the fiducial landmarks enabled co-
egistration of datasets in an automated fashion. The
oint-based coregistration tool kit in OsiriX shareware
used images after identification of fiducial landmarks in
espective modalities. Fiducial landmarks were tagged with
oint markers to define their XYZ coordinates. With these
oordinates, data were resampled, rotated, and translated to
atch the image matrices and finally fused.
RI. We performed in vivo MRI on Day 1 and Day 21
fter MI in the same mice that were imaged by FMT-CT to
Figure 2 Blood Monocytosis Increases Number of Monocytes R
(A) Original flow cytometry dot plots of blood and infarct tissue in wild-type and ap
(B) Enumeration of cells shows significantly increased blood and tissue levels forollow the functional impact of infarct healing on the
volution of heart failure. A 7-T horizontal-bore Pharmas-
an (Bruker, Billerica, Massachusetts) was used to obtain
yperenhancement cine images of the LV short axis after
njection of gadolinium-diethylenetriaminepentaacetic acid
Gd-DTPA) (Berlex, Wayne, New Jersey) at a dosage of 0.3
mol/kg (22). We employed ECG and respiratory gating
ith a T1-weighted gradient echo sequence (echo time 2.7
s, 16 frames/RR interval; flip angle 60°; in-plane resolu-
ion 200 200 m; slice thickness 1 mm). Cardiac volumes
ere quantitated from 6 to 8 short-axis imaging slices
overing the LV. The infarcted area was identified in
nd-diastolic frames as: 1) hypokinetic in cine-loops, and 2)
yperenhancing after Gd-DTPA injection. Changes of
arameters over time were then calculated (i.e., Delta
nd-diastolic volume [EDV]  EDVday21  EDVday1).
tatistical analysis. Results are expressed as mean  SEM.
tatistical comparisons between 2 groups were evaluated by
tudent t test. A p value 0.05 was considered statistically
ited Into the Infarct
mice 5 days after coronary ligation.
matory Ly-6Chi monocytes in apoE/ mice.ecru
oE/
inflam
s
c
R
W
i
a
F
c
b
t
m
L
(
L
c
i
m
n
f
L
a
o
1633JACC Vol. 55, No. 15, 2010 Panizzi et al.
April 13, 2010:1629–38 Fluorescence Molecular Tomography-CT in Infarcted ApoE/ Miceignificant. No corrections were made for multiple
omparisons.
esults
e first investigated whether elevated blood levels of
nflammatory Ly-6Chi monocytes in atherosclerotic
poE/ mice (12) (corroborated in the present study,
ig. 2) result in increased and prolonged presence of these
ells in the healing infarct. We collected infarcts on Day 5,
ecause this time point represents the start of Phase 2 (i.e.,
he healing phase dominated by anti-inflammatory Ly-6Clo
onocytes in wild-type mice) (16). Although the number of
Figure 3 Infarct Healing Is Impaired in Atherosclerotic ApoE/
(A) Immunoreactive staining and quantitation for the presence of the imaging targ
MMP-2, MMP-9, vascular endothelial growth factor (VEGF), and CD31 was profiled.
expression of MAC-3 and CD68 corroborate in vivo and ex vivo findings of increase
tion of myeloperoxidase (MPO) and tumor necrosis factor-alpha (TNF) is higher in
trol, we determined apoE, which was undetectable in apoE/ mice. *p  0.05; *y-6Chi monocytes in wild-type mice had already declined
1.1  0.1  104 cells in heart), we found 10 more
y-6Chi cells in infarcts of apoE/ mice (14.4 5.8 104
ells, p 0.05) (Fig. 2). The ratio of Ly-6Chi to Ly-6Clo in
nfarct tissue was 1.2 for wild-type and 2.2 for apoE/
ice. ApoE/ mice also showed higher numbers of
eutrophils and macrophages (Fig. 2); the latter likely derive
rom Ly-6Chi monocytes (12).
Monocyte subsets exhibit functional heterogeneity, and
y-6Chi monocytes selectively show higher inflammatory
ctivity (23). Thus, we investigated the inflammatory status
f infarct tissue by immunohistochemistry and gene expres-
e
ease Cathepsin B and F4/80 positive macrophages. Furthermore, presence of
ification 200, the scale bar denotes 100 m. (B) Quantitative PCR: higher
recruitment into the infarct of apolipoprotein E knockout (apoE/). Transcrip-
/ mice, whereas transforming growth factor-beta (TGF) is reduced. As a con-
0.001.Mic
et prot
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Fluorescence Molecular Tomography-CT in Infarcted ApoE/ Mice April 13, 2010:1629–38ion analysis. Quantitative staining showed increased ca-
hepsin B (target enzyme of the fluorescent protease imag-
ng sensor), MMP-2, and MMP-9 enzymes in infarcts of
poE/ compared with wild-type mice (Fig. 3A). The
umber of CD31 microvessels was higher in apoE/
ice, likely due to higher inflammatory cell numbers that
huttle in proteases and VEGF (Fig. 3A). Interestingly,
MP9 has been reported to promote VEGF release in
ancer (24). mRNA levels of the inflammatory enzyme
PO and TNF-alpha increased in apoE/ infarct tissue,
hereas mRNA levels of TGF-beta—a protein that stim-
lates fibroblast function and collagen deposition to
trengthen the evolving infarct scar (1–4)—declined (Fig.
B). PCR confirmed increased levels of Ly-6C (monocytes)
nd CD68 and MAC-3 (macrophages) (Fig. 3B). We also
ompared monocyte subsets directly for proteolysis and
hagocytosis. This involved IV injection of an activatable
an-cathepsin sensor (Prosense-680) and a phagocytosis
ensor (CLIO-750), followed by flow cytometry analysis of
ell suspensions isolated from infarcts. Ly-6Chi monocytes
howed 7.5-fold more protease activity than their Ly-6Clo
ounterparts in vivo, whereas both subsets had similar
er Cell Fluorescence 24 h After IV InjectionTable 1 Per Cell Fluorescence 24 h After IV Injection
Cell Prosense CLIO
Ly-6Chi monocyte 8,902 2,747 1,191 86
Ly-6Clo monocyte 1,433 343 1,125 141
Neutrophil 1,930 200 340 56
Lymphocyte 525 103 214 51
ean fluorescence intensity/cell after injection of respective sensor measured by flow cytometry.
ells were retrieved from infarcts.
Figure 4 Image Fusion
(A) Multimodal imaging cartridge. (B to E) Fluorescence molecular tomography in
(B, C) Coronal CT and FMT-CT. (D) Maximum intensity projection of fused FMT-CT.
tains iodine CT contrast. (E) Correlation between CT and FMT-CT dimensions show
cardial infarction injected with CLIO-750. Arrows denote fiducial landmarks used fohagocytic activity (Table 1). Both activities were lower in
D11b cells (mostly T and B cells) and neutrophils (Table
). These data indicate that the prolonged Phase I Ly-6Chi
onocyte response in infarcts of apoE/ mice associates
ith heightened inflammatory activity.
The above results indicate that the activatable pan-
athepsin sensor should report selectively on Ly-6Chi
onocytes in vivo, whereas the phagocytosis sensor indi-
ates the presence of both monocyte subsets. Thus, we
hought to use these agents in combination with fusion
MT-CT imaging to map the monocyte response in infarct
issues in vivo (FMT detects molecular signal, whereas CT
ives anatomical information). Initially, we performed
hantom validation experiments to evaluate the accuracy of
usion of datasets obtained from the 2 imaging modalities.
hantoms placed in a multimodality mouse holder (Fig. 4A)
nderwent imaging with both modalities. Fusion was per-
ormed with fiducial landmarks on the holder frame (Figs.
B to 4D). We then measured the distance between the
hantom cavity, which was filled with a CT contrast/
uorochrome solution, and the edge of the phantom on CT
mages (Fig. 4B). The same measurement was repeated on
he fused FMT-CT dataset, but here the cavity was iden-
ified using the fluorescence signal. We observed excellent
patial coregistration and correlation (R2  0.994, p 
.001) (Figs. 4D and 4E). Next, we evaluated a wild-type
ouse after coronary ligation injected with CLIO-750 to
eport on phagocytic activity. CT allowed assessment of
natomy, whereas FMT-CT fusion showed the fluores-
ence signal localized in the left side of the thoracic cavity,
finding that was consistent with uptake into the infarct
ction with anatomical computed tomography (FMT-CT) phantom imaging.
ell inside the phantom is filled with fluorochrome VT-680 and in addition con-
d agreement of fused data. (F to K) CT, FMT, and FMT-CT in a mouse with myo-
on. MIP  Maximum Intensity Projection.conjun
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April 13, 2010:1629–38 Fluorescence Molecular Tomography-CT in Infarcted ApoE/ Miceegion (Figs. 4F to 4K). We then investigated in vivo
athepsin and phagocytic activities in infarcts of apoE/
ice during monocytic healing Phase 2, when the protease
ctivity has passed its peak (21) and the number of Ly-6Chi
onocytes has declined in infarcts of wild-type mice (16).
e first assessed infarct size by delayed enhancement MRI,
s outlined in the serial imaging protocol (Fig. 1), which
howed no significant difference between groups (wild-type
6  3%, apoE/ 14  2%, p  0.6). In some apoE/
ice, CT showed vascular calcification in the aortic wall
oincident with atherosclerotic plaques. Two-dimensional
nd 3D reconstructions of fused FMT-CT images showed
rosense-680 and CLIO-750 signals in the apex of the LV.
orresponding to the increase of Ly-6Chi monocytes and
acrophages by flow cytometry, histology, and PCR data,
e found higher protease and phagocytic activity in infarcts
f apoE–/– mice (p  0.05) (Fig. 5A). Ex vivo reflectance
uorescence imaging of myocardial rings harvested from a
eparate group of mice corroborated our in vivo FMT
ndings. The target-to-background ratio for both molecular
robes was higher in the infarct of apoE/ mice when
ompared with wild-type mice (p  0.0001) (Fig. 5B). Ex
ivo, Prosense-680 signal was 2.7-fold and CLIO-750
ignal 3.3-fold higher in apoE/ infarcts when compared
ith wild-type mice, similar to the differences seen in vivo
FMT for Prosense-680 and CLIO-750: 2.9- and 2.6-fold
Figure 5 FMT-CT Imaging of Infarct Healing
(A) FMT-CT 5 days after myocardial infarction. Arrows denote apical infarct, arr
dimensional Prosense and CLIO FMT-CT images, arrows point toward infarct sign
reflectance imaging corroborates in vivo FMT findings. TBR  target to background ratncrease in apoE/ mice, respectively). Of note, the iuorescence of infarcts in wild-type mice, although lower
han that in apoE/ animals, significantly exceeded the
ignals in sham-operated control subjects that received the
olecular sensors without coronary artery ligation (p 
.0001).
We next quantitated LV remodeling with serial cine
RI. We observed similar myocardial hypertrophy in
ild-type and apoE/ mice (Fig. 6). Although ejection
raction was comparable between groups on Day 1 after MI,
nhanced ventricular dilation of the LV tripled its decline
etween Day 1 and Day 21 in apoE/ mice. The MRI-
erived increase in end-diastolic volume positively corre-
ated with protease activity measured with FMT (Prosense-
80 activation, R2  0.39, p  0.003) but not with
hagocytic activity (CLIO-750 uptake, p  0.24). The
orrelation of FMT-derived protease signal with LV dila-
ion implies that: 1) protease sensing can predict post-MI
eart failure; and 2) prolonged retention of proteolytic
y-6Chi monocytes impairs infarct healing and ventricular
emodeling. Heart and body weights were comparable in
ild-type and apoE/ mice (Table 2).
Phenotypic changes in apoE/ mice with high-
holesterol diet might not be limited to the change in
onocyte subsets. Thus, we thought to investigate whether
y-6Chi monocytosis is causally linked to LV remodeling.
o this end, we investigated an independent mouse model
ad denotes calcification, presumably in an atherosclerotic lesion. On 3-
owheads denote fluorescence signal in the carotid artery. (B) Ex vivo fluorescence
 0.05. Abbreviations as in Figures 3 and 4.owhe
al. Arr
io. *pn which monocytosis is not related to germline deletion of
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ild-type mice by repeated injections of lipopolysaccaride
LPS) (20). Flow cytometry on Day 5 after MI showed
ncreased numbers of monocytes in blood and in infarcts,
omparable to our observations in apoE/ mice (Fig. 7A).
MT-CT showed increased protease and phagocytic signal,
nd MRI showed increased ventricular dilation in LPS-
reated mice in vivo (Fig. 7A). Thus, increased inflamma-
ion in infarct tissue and subsequent heart failure are both
Figure 6 Serial Cardiac MRI
Initial assessment of infarct size by delayed enhancement (DE) after injection of G
was enhanced in apoE/ mice, which resulted in significantly worse ejection frac
MI  myocardial infarction.
eart and Body WeightsTable 2 Heart and Body Weights
Heart Weight (mg) Body Weight (g)
C57/BL6 167.9 4.0 22.3 1.5
ApoE/ 171.5 9.4 23.0 0.8oeart and body weights 3 weeks after myocardial infarction.ecapitulated in wild-type mice with artificially induced
onocytosis. Of note, the LPS treatment did not alter the
ecruitment of neutrophils, which represent another impor-
ant cellular mediator of inflammation after MI (Fig 7A).
lso, in vivo depletion of neutrophils in apoE/ mice did
ot restore post-MI remodeling (Fig 7B). These data
ndicate that the number of Ly-6Chi monocytes recruited
nto the infarct has direct consequences on LV remodeling.
iscussion
onocyte/macrophages contribute centrally to wound heal-
ng. Their known functions include removal of necrotic
ebris, propagation of angiogenesis, and regulation of ex-
racellular matrix turnover (23,25). These phagocytes elab-
(arrows) showed similar values in both groups. Over time, ventricular dilatation
Day 21 after MI. *p  0.05. EDV  end-diastolic volume; LV  left ventricular;d-DTPA
tion onrate regulatory cytokines, chemokines, and proteolytic
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April 13, 2010:1629–38 Fluorescence Molecular Tomography-CT in Infarcted ApoE/ Micenzymes, all of which participate in tissue repair (1–4).
xperimental (16,26) and clinical data (27) show that abroga-
ion of monocytes compromises infarct healing. However, little
s known about the downregulation of innate immune cell
ctivity and associated inflammation after the initial burst
riggered by ischemic myocardial injury. Here we show that
ffective infarct healing necessitates timely and coordinated
esolution of inflammation. The endogenous repair response
hat follows MI requires immune cell populations that are
rofoundly altered during atherosclerosis, the condition that
auses MI in most patients. Specifically, we found that
y-6Chi monocytes, which are chronically expanded in the
lood pool of atherosclerotic apoE/ mice, impair infarct
ealing through prolonged presence in the infarct, delayed
nset of monocytic Phase 2, and deregulated resolution of
nflammation.
The increased circulating pool of Ly-6Chi monocytes in
poE/ mice corresponded to a higher number of this
nflammatory subset lingering in the infarct 5 days after MI,
resumably because an excess of these cells in the circulation
eads to their more abundant recruitment. The gene expres-
ion profile of apoE/ infarcts remained pro-inflammatory
hen inflammation was already waning in wild-type in-
arcts. For instance, MPO activity peaks 2 days after MI in
ild-type mice and quickly resolves thereafter (28). In the
urrent study, we found that MPO transcription was still
3-fold higher in apoE/ infarcts on Day 5. Therefore,
Figure 7 LPS-Induced Blood Monocytosis and Neutrophil Deple
(A) Flow cytometry on Day 5 and serial imaging in wild-type mice in which blood m
tained monocyte presence in the infarct on Day 5, increased protease and phagoc
neutrophils were depleted with injections of anti-Ly-6G antibody show similar inflam
in Figures 4 and 6.e speculate that the increased residual Ly-6Chi monocytes in the myocardial infarcts of apoE/ mice hampered
ransition toward an anti-inflammatory healing microenvi-
onment. Future studies will need to determine the precise
echanisms responsible for elevated Ly-6Chi monocyte
resence in the myocardium of these mice. Notably, hyper-
holesterolemia has been shown to promote monocyte
roliferation and survival (12) and might therefore modulate
hase I to Phase II transition. However, LPS-induced
onocytosis also resulted in sustained infarct inflammation
nd accelerated ventricular dilation, suggesting that blood
onocytosis might hamper resolution of inflammation in
he infarct. Furthermore, although neutrophil depletion did
ot improve remodeling in apoE/ mice, the role of the
rolonged presence of these cells requires further study.
The use of noninvasive molecular and physiological
maging (29) allowed us to correlate the inflammatory
ilieu in the infarct (30) in vivo with the development of
eart failure. Infarcts of apoE/ mice had higher protease
ctivity and increased phagocytic rates compared with those
n wild-type mice. Flow cytometric probe distribution stud-
es suggested that this constellation is caused by a high
umber of Ly-6Chi monocytes in apoE/ infarcts, because
he inflammatory subset activates more protease sensor
oieties per monocyte. Consequently, ventricular dilation
as accelerated and resulted in a 16% lower ejection fraction
weeks after MI in apoE/ mice. Cathepsin activity, by
irtue of its association with Ly-6Chi monocytes, is an
osis was induced by lipopolysaccharide (LPS). Blood monocytosis led to sus-
gnal on FMT, and accelerated left ventricular dilation. (B) ApoE/ mice in which
n in the infarct by FMT-CT and remodeling by MRI. *p  0.05. Abbreviations astion
onocyt
ytic si
mationtegral component of the early monocytic phase of myo-
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ctivity and LV dilation suggests that a prolonged Phase I or
compromised Phase II predisposes to heart failure. Trans-
ation of this diagnostic concept might permit identification
f infarct patients at accentuated risk for developing heart
ailure.
The results of our study point to inflammatory mono-
ytes as a potential therapeutic target in post-MI heart
ailure, whose modulation might augment healing and
ttenuate LV remodeling. Future work should search for
easures to support the Ly-6Chi¡ Ly-6Clo subset re-
ruitment switch and to chaperone the healing microen-
ironment toward dampened inflammation during the
econd monocytic phase. Molecular imaging that inter-
ogates monocytic targets in injured myocardium in
onjunction with quantitation of monocyte subsets in the
irculation might provide prognostic information and
elp guide therapies to promote favorable ventricular
emodeling after MI.
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